US 9834587
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
granted A61KA61K38/00A61K38/47
Quick answer
US patent 9834587 (Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN PHARMACEUTICAL INC.
- Grant date
- Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K38/00, A61K38/47, A61P, A61P3/00